Log In
BCIQ
Print this Print this
 

Meninge ACYW

  Manage Alerts
Collapse Summary General Information
Company Sanofi
DescriptionSecond generation meningococcal conjugate infant vaccine
Molecular Target
Mechanism of ActionVaccine
Therapeutic ModalityPreventive vaccine
Latest Stage of DevelopmentPhase III
Standard IndicationMeningitis
Indication DetailsPrevent meningococcal infection in adults 56 years of age and older; Prevent meningococcal infection in infants
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

1

0

0

0


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone

03/08/2016

Undisclosed

Undisclosed

Undisclosed

Get a free BioCentury trial today